One of the major challenges in cancer treatment is the recurrence of the disease after initial therapy. CSCs are inherently resistant to conventional therapies, which often kill the bulk of the tumor cells but leave CSCs intact. These surviving cells can then regenerate the tumor, leading to recurrence. Understanding this mechanism is crucial for developing more effective treatment strategies.